Physical recovery across care pathways up to 12 months after hospitalization for COVID-19: A multicenter prospective cohort study (CO-FLOW) - The Lancet Regional Health – Europe

2022-09-17 01:11:14 By : Mr. Andy Fu

If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

Please enter a term before submitting your search.

LM Bek, JC Berentschot, MH Heijenbrok-Kal, et al. Symptoms persisting after hospitalization for COVID-19: 12 months interim results of the COFLOW study. medRxiv. doi: https://doi.org/10.1101/2021.12.11.21267652 (preprint: 13 Dec 2021).

LM Bek, JC Berentschot, MH Heijenbrok-Kal, et al. Symptoms persisting after hospitalization for COVID-19: 12 months interim results of the COFLOW study. medRxiv. doi: https://doi.org/10.1101/2021.12.11.21267652 (preprint: 13 Dec 2021).

Richtlijnendatabase. Indicatiestelling revalidatietraject en hertriage. 2021.https://richtlijnendatabase.nl/richtlijn/covid-19/startpagina_-_langdurige_klachten_en_revalidatie_na_covid-19/startpagina_-_revalidatie_na_covid-19/indicatiestelling_revalidatietraject_en_hertriage_bij_covid-19.html. Accessed 16 June 2022.

Verenso. Behandeladvies Geriatrische Revalidatiezorg (GR). 01-12-2020. https://www.verenso.nl/themas-en-projecten/infectieziekten/covid-19-coronavirus/behandeladvies-gr. Accessed 16 June 2022.

WHO. Rehabilitation. 2021. https://www.who.int/news-room/fact-sheets/detail/rehabilitation. Accessed 16 June 2022.

Richtlijnendatabase. Indicatiestelling revalidatietraject en hertriage. 2021.https://richtlijnendatabase.nl/richtlijn/covid-19/startpagina_-_langdurige_klachten_en_revalidatie_na_covid-19/startpagina_-_revalidatie_na_covid-19/indicatiestelling_revalidatietraject_en_hertriage_bij_covid-19.html. Accessed 16 June 2022.

Verenso. Behandeladvies Geriatrische Revalidatiezorg (GR). 01-12-2020. https://www.verenso.nl/themas-en-projecten/infectieziekten/covid-19-coronavirus/behandeladvies-gr. Accessed 16 June 2022.

Richtlijnendatabase. Indicatiestelling revalidatietraject en hertriage. 2021.https://richtlijnendatabase.nl/richtlijn/covid-19/startpagina_-_langdurige_klachten_en_revalidatie_na_covid-19/startpagina_-_revalidatie_na_covid-19/indicatiestelling_revalidatietraject_en_hertriage_bij_covid-19.html. Accessed 16 June 2022.

WHO. Rehabilitation. 2021. https://www.who.int/news-room/fact-sheets/detail/rehabilitation. Accessed 16 June 2022.

Rijksinstituut voor Volksgezondheid en Milieu. Covid-19 cumulatieve aantallen per gemeente. 2022. https://data.overheid.nl/dataset/11508-covid-19-aantallen-gemeente-cumulatief. Accessed 16 June 2022.

WHO. Rehabilitation. 2021. https://www.who.int/news-room/fact-sheets/detail/rehabilitation. Accessed 16 June 2022.

LM Bek, JC Berentschot, MH Heijenbrok-Kal, et al. Symptoms persisting after hospitalization for COVID-19: 12 months interim results of the COFLOW study. medRxiv. doi: https://doi.org/10.1101/2021.12.11.21267652 (preprint: 13 Dec 2021).

Richtlijnendatabase. Indicatiestelling revalidatietraject en hertriage. 2021.https://richtlijnendatabase.nl/richtlijn/covid-19/startpagina_-_langdurige_klachten_en_revalidatie_na_covid-19/startpagina_-_revalidatie_na_covid-19/indicatiestelling_revalidatietraject_en_hertriage_bij_covid-19.html. Accessed 16 June 2022.

Verenso. Behandeladvies Geriatrische Revalidatiezorg (GR). 01-12-2020. https://www.verenso.nl/themas-en-projecten/infectieziekten/covid-19-coronavirus/behandeladvies-gr. Accessed 16 June 2022.

WHO. Rehabilitation. 2021. https://www.who.int/news-room/fact-sheets/detail/rehabilitation. Accessed 16 June 2022.

Rijksinstituut voor Volksgezondheid en Milieu. Covid-19 cumulatieve aantallen per gemeente. 2022. https://data.overheid.nl/dataset/11508-covid-19-aantallen-gemeente-cumulatief. Accessed 16 June 2022.

DOI: https://doi.org/10.1016/j.lanepe.2022.100485

Permitted Read, print & download Redistribute or republish the final article Text & data mine Translate the article Reuse portions or extracts from the article in other works Sell or re-use for commercial purposes Elsevier's open access license policy

We use cookies to help provide and enhance our service and tailor content and ads. To update your cookie settings, please visit the Cookie Preference Center for this site. Copyright © 2022 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals. Privacy Policy   Terms and Conditions   Accessibility